金达威(002626)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002626 金达威

已收盘 07-26 15:00:00

{"stockData":{"symbol":"002626","market":"SZ","secType":"STK","nameCN":"金达威","latestPrice":13.53,"timestamp":1721977407000,"preClose":13.4,"halted":0,"volume":3911900,"delay":0,"floatShares":610000000,"shares":610000000,"eps":0.4272,"marketStatus":"已收盘","marketStatusCode":5,"change":0.13,"latestTime":"07-26 15:00:00","open":13.52,"high":13.74,"low":13.41,"amount":53013200,"amplitude":0.0246,"askPrice":13.54,"askSize":82,"bidPrice":13.53,"bidSize":96,"shortable":0,"etf":0,"ttmEps":0.4272,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":13.4,"symbolType":"stock","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":14.74,"lowLimit":12.06,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":609934771,"pbRate":2.04,"roa":"--","roe":"1.79%","epsLYR":0.45,"committee":-0.11,"marketValue":8252000000,"floatMarketCap":8251000000,"peRate":31.671349,"changeRate":0.0097,"turnoverRate":0.0064,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-07-29。"},"requestUrl":"/m/hq/s/002626","defaultTab":"news","newsList":[{"id":"2454039355","title":"金达威（002626）7月25日主力资金净卖出243.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454039355","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454039355?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:25","pubTimestamp":1721957103,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月25日收盘，金达威报收于13.4元，下跌1.62%，换手率0.62%，成交量3.76万手，成交额5080.73万元。近5日资金流向一览见下表：金达威融资融券信息显示，融资方面，当日融资买入468.35万元，融资偿还306.36万元，融资净买入161.99万元。金达威主营业务：主要从事营养保健食品、饲料添加剂的研发、生产及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600013994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","002626","BK0197","BK0191","BK0077"],"gpt_icon":0},{"id":"2453714830","title":"金达威：维生素公司已恢复正常生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2453714830","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453714830?lang=zh_cn&edition=full","pubTime":"2024-07-24 18:04","pubTimestamp":1721815459,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)07月24日在投资者关系平台上答复投资者关心的问题。投资者：请问厦门维生素公司因安全生产事故整改，现在复产没有？目前维A和D3产能是否达到设计能力？金达威董秘：您好，维生素公司已恢复正常生产。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400040541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0191","BK0226","002626","BK0077"],"gpt_icon":0},{"id":"2453203530","title":"金达威最新公告：子公司在美国设立保健品销售合资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2453203530","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453203530?lang=zh_cn&edition=full","pubTime":"2024-07-24 16:21","pubTimestamp":1721809270,"startTime":"0","endTime":"0","summary":"金达威公告，近日收到全资子公司VITABEST NUTRITION,INC.的通知，其与YOLAWANT INC.在美国加利福尼亚州共同投资设立一家合资公司ORGARA NUTRITION LLC。ORGARA NUTRITION LLC的主要业务为保健品的销售，设立ORGARA NUTRITION LLC有利于扩大公司保健品业务在北美市场的拓展力度，提升公司海外业务的竞争能力，符合公司中长期的发展战略。预计对公司本年度的生产经营不会产生重大影响。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400036386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0197","BK0191","BK0077","002626"],"gpt_icon":0},{"id":"2453022272","title":"金达威(002626.SZ)子公司拟参设ORGARA NUTRITION LLC 推进海外业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2453022272","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453022272?lang=zh_cn&edition=full","pubTime":"2024-07-24 15:59","pubTimestamp":1721807997,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金达威(002626.SZ)公告，公司近日收到全资子公司VITABEST NUTRITION,INC.的通知，其与YOLAWANT INC.(简称Yolawant) 在美国加利福尼亚州共同投资设立一家合资公司ORGARA NUTRITION LLC，VITABEST NUTRITION,INC.拟出资25.5万美元，权益比例为51%。公告显示，ORGARA NUTRITION LLC的主要业务为保健品的销售，设立ORGARA NUTRITION LLC有利于扩大公司保健品业务在北美市场的拓展力度，提升公司海外业务的竞争能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1154924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIRI","002626","BK0191","BK0077","BK0197","BK0226","BK4139"],"gpt_icon":0},{"id":"2453058131","title":"金达威：公司目前未有该方面的信息披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2453058131","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453058131?lang=zh_cn&edition=full","pubTime":"2024-07-23 22:00","pubTimestamp":1721743243,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)07月23日在投资者关系平台上答复投资者关心的问题。投资者：请问贵公司有促炎蛋白IL-11技术部署吗？金达威董秘：您好，感谢您的关注，公司目前未有该方面的信息披露。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300042657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002626","BK0191","BK0077","BK0197","BK0226"],"gpt_icon":0},{"id":"2453521247","title":"金达威：获得一项发明专利证书 有助于增强公司核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2453521247","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453521247?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:48","pubTimestamp":1721641725,"startTime":"0","endTime":"0","summary":"中国财富通7月22日 - 金达威（002626）公告称，控股子公司江苏诚信药业有限公司、全资孙公司金达威生物技术（江苏）有限公司，近日收到国家知识产权局颁发的1件发明专利证书，发明名称为一种烟酰胺腺嘌呤二核苷酸的纯化方法。上述专利的取得不会对公司生产经营产生重大影响，但有利于公司的技术创新，充分发挥自主知识产权优势，进一步完善知识产权保护体系，增强公司的核心竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=YYyjoLiCBY4%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0197","BK0077","BK0226","BK0191","002626"],"gpt_icon":0},{"id":"2453756911","title":"金达威最新公告：取得发明专利证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2453756911","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453756911?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:41","pubTimestamp":1721637677,"startTime":"0","endTime":"0","summary":"金达威公告，公司控股子公司江苏诚信药业有限公司、全资孙公司金达威生物技术（江苏）有限公司近日收到国家知识产权局颁发的1件发明专利证书，发明名称：一种烟酰胺腺嘌呤二核苷酸的纯化方法。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200020731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002626","BK0191","BK0197","BK0077","BK0226"],"gpt_icon":0},{"id":"2451522266","title":"金达威（002626）7月12日主力资金净卖出539.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451522266","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451522266?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:20","pubTimestamp":1721006419,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月12日收盘，金达威报收于13.58元，下跌2.93%，换手率1.08%，成交量6.61万手，成交额9028.64万元。近5日资金流向一览见下表：金达威融资融券信息显示，融资方面，当日融资买入1092.55万元，融资偿还688.05万元，融资净买入404.5万元。金达威主营业务：主要从事营养保健食品、饲料添加剂的研发、生产及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500002657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","002626","BK0191","BK0077","BK0226"],"gpt_icon":0},{"id":"2449252700","title":"金达威：公司维生素D3产能为1600吨/年（折合50万IU/g的规格）","url":"https://stock-news.laohu8.com/highlight/detail?id=2449252700","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449252700?lang=zh_cn&edition=full","pubTime":"2024-07-05 18:04","pubTimestamp":1720173873,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)07月05日在投资者关系平台上答复投资者关心的问题。投资者：请问董秘，公司VD3产能多少？目前订单情况是否饱和金达威董秘：您好，公司维生素D3产能为1600吨/年（折合50万IU/g的规格）。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500037208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002626","BK0197","BK0226","BK0191","BK0077"],"gpt_icon":0},{"id":"2448445802","title":"金达威：维生素A和辅酶Q10，营养保健食品有单独披露，营养保健食品含nmn成品","url":"https://stock-news.laohu8.com/highlight/detail?id=2448445802","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448445802?lang=zh_cn&edition=full","pubTime":"2024-07-04 18:04","pubTimestamp":1720087472,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)07月04日在投资者关系平台上答复投资者关心的问题。投资者：请问贵司旗下，例如VA，Nmn，D3等系列产品销量到什么程度可以达到披露标准？还请不吝解析！金达威董秘：您好，维生素A和辅酶Q10，营养保健食品有单独披露，营养保健食品含nmn成品。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400035455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0191","002626","BK0197","BK0077"],"gpt_icon":0},{"id":"2448193163","title":"金达威：维生素K2销售金额占比未达到披露标准","url":"https://stock-news.laohu8.com/highlight/detail?id=2448193163","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448193163?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:00","pubTimestamp":1719932439,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威07月02日在投资者关系平台上答复投资者关心的问题。投资者：请问贵司目前维生素K2的年销量大概有多少，在全球市场中占比多少金达威董秘：您好，维生素K2销售金额占比未达到披露标准。投资者：近期有消息说维生素D3从最低50多涨价到了目前100多，请问贵公司目前维生素D3产销情况如何？金达威董秘：您好，维生素D3市场价格请关注专业网站的信息。子公司金达威维生素公司目前生产正常。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200035392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0226","BK0077","BK0191","002626"],"gpt_icon":0},{"id":"2446321155","title":"金达威（002626）6月26日主力资金净买入86.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446321155","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446321155?lang=zh_cn&edition=full","pubTime":"2024-06-27 09:20","pubTimestamp":1719451246,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月26日收盘，金达威报收于14.49元，下跌0.69%，换手率1.87%，成交量11.42万手，成交额1.63亿元。近5日资金流向一览见下表：金达威融资融券信息显示，融资方面，当日融资买入1469.77万元，融资偿还1450.58万元，融资净买入19.19万元。金达威主营业务：主要从事营养保健食品、饲料添加剂的研发、生产及销售业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062700013669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0077","002626","BK0191","BK0226"],"gpt_icon":0},{"id":"2446356028","title":"金达威最新公告：全资子公司取得食品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2446356028","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446356028?lang=zh_cn&edition=full","pubTime":"2024-06-26 16:37","pubTimestamp":1719391024,"startTime":"0","endTime":"0","summary":"金达威公告，公司全资子公司内蒙古金达威药业有限公司近日收到呼和浩特市行政审批和政务服务局下发的《食品生产许可证》，新增“吡咯并喹啉醌二钠盐”、“肌醇”的生产许可。吡咯并喹啉醌是一种新有机辅酶，可作为原料用于能量饮料、运动饮料、电解质饮料等食品。肌醇是一种广泛存在于动植物中的B族维生素，是微生物及动物生长的必要元素。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600032502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0077","BK0191","002626","BK0226"],"gpt_icon":0},{"id":"2446358627","title":"金达威(002626.SZ)子公司取得食品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2446358627","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446358627?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:43","pubTimestamp":1719387827,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金达威(002626.SZ)发布公告，公司全资子公司内蒙古金达威药业有限公司(以下简称金达威药业)于近日收到呼和浩特市行政审批和政务服务局下发的《食品生产许可证》，新增“吡咯并喹啉醌二钠盐”、“肌醇”的生产许可。吡咯并喹啉醌二钠盐及肌醇项目取得食品生产许可证，有利于公司产品结构优化，丰富公司的产品布局，进一步增强公司核心竞争力。新产品的市场推广有一个过程，预计对公司本年业绩无重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1140718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0191","002626","BK0197","BK0077","BK0226"],"gpt_icon":0},{"id":"2446581940","title":"金达威：公司维生素D3产能为1600吨（折合50万IU/g的规格）","url":"https://stock-news.laohu8.com/highlight/detail?id=2446581940","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446581940?lang=zh_cn&edition=full","pubTime":"2024-06-25 19:02","pubTimestamp":1719313350,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)06月25日在投资者关系平台上答复投资者关心的问题。投资者：董秘您好，维生素D3市场均价为78元/公斤，较上月上涨了41.82%，且货源难寻，请问公司维生素D3的产能是多少？2023年的销量是多少？今年截止到现在的销量是多？金达威董秘：您好，公司维生素D3产能为1600吨（折合50万IU/g的规格）。去年和今年的销量未授权披露，请理解。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500035905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0226","BK0191","002626","BK0197"],"gpt_icon":0},{"id":"2446002903","title":"金达威：公司维生素D3的营收占比较小，产量未达到披露要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2446002903","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446002903?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:00","pubTimestamp":1719244836,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)06月24日在投资者关系平台上答复投资者关心的问题。投资者：公司VD3实际产量多少？请直接告知金达威董秘：您好，公司维生素D3的营收占比较小，产量未达到披露要求。感谢您的关注！投资者：请问公司在维生素D的市场地位如何？谢谢金达威董秘：您好，公司维生素D3产能为1600吨（折合50万IU/g的规格）。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500000006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002626"],"gpt_icon":0},{"id":"2444421640","title":"金达威：是厦门金达威投资公司投资的","url":"https://stock-news.laohu8.com/highlight/detail?id=2444421640","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444421640?lang=zh_cn&edition=full","pubTime":"2024-06-19 18:04","pubTimestamp":1718791447,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威(002626)06月19日在投资者关系平台上答复投资者关心的问题。投资者：你好，金达威董秘，请问金达威医疗公司是由厦门金达威投资有限公司投资的还是由厦门金达威集团股份公司投资的？也就是说金达威医疗公司的所有权是属于上面两家公司的哪一家公司的？金达威董秘：您好，是厦门金达威投资公司投资的。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900036339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0077","BK0226","BK0191","002626"],"gpt_icon":0},{"id":"2444152626","title":"金达威：该产能为设计产能，产品以销定产","url":"https://stock-news.laohu8.com/highlight/detail?id=2444152626","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444152626?lang=zh_cn&edition=full","pubTime":"2024-06-17 18:03","pubTimestamp":1718618627,"startTime":"0","endTime":"0","summary":"证券之星消息，金达威06月17日在投资者关系平台上答复投资者关心的问题。投资者：具公开资料示，贵公司NMN年产能为500吨，如果这500吨NMN全部造成纯NMN胶囊，按现在NMN18000最优惠750元一瓶的价格，其产值是500吨×1000公斤×1000克÷18克×750元=20833333333.33元，即208亿元人民币，为什么去年全面贵公司营收才30亿人民币出头？另，目前NMN相关产品国内外电商平台销售量年增长率是多少？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061700022382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0191","002626","BK0226","BK0077"],"gpt_icon":0},{"id":"2441426247","title":"金达威：接到平台对各品牌商家关于“含NMN成分产品建议做下架处理”的通告","url":"https://stock-news.laohu8.com/highlight/detail?id=2441426247","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441426247?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:03","pubTimestamp":1717578197,"startTime":"0","endTime":"0","summary":"公司旗下品牌产品覆盖心脑血管、骨骼健康、男性健康、女性健康、综合健康等多系列产品，超过300多个SKU，NMN产品占品牌全球销售比重较小，对品牌全球收入影响有限。目前品牌业务正常有序开展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500034361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","002626","BK0077","BK0191","BK0226"],"gpt_icon":0},{"id":"2440402389","title":"金达威最新公告：控股子公司DRB完成对Activ Nutritional,LLC100%股权收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2440402389","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440402389?lang=zh_cn&edition=full","pubTime":"2024-06-04 17:11","pubTimestamp":1717492277,"startTime":"0","endTime":"0","summary":"金达威公告，控股子公司Doctor's Best Inc.(DRB)已完成对Activ Nutritional, LLC 100%股权的收购。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060400033670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0077","BK0226","BK0191","002626"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-10-28","address":"福建省厦门市海沧区海沧新阳工业区","stockEarnings":[{"period":"1week","weight":-0.065},{"period":"1month","weight":-0.0663},{"period":"3month","weight":-0.0162},{"period":"6month","weight":-0.0099},{"period":"1year","weight":-0.2826},{"period":"ytd","weight":-0.1596}],"companyName":"厦门金达威集团股份有限公司","boardCode":"AI0014","perCapita":"11579股","boardName":"食品制造业","registeredCapital":"60993万元","compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0275},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1013},{"period":"ytd","weight":-0.0282}],"survey":"　　厦门金达威集团股份有限公司主营业务为保健食品（包含保健食品原料和保健食品终端产品）和饲料添加剂的研发、生产及销售。公司主要产品有辅酶Q10、DHA、ARA、维生素K、纳豆激酶、PQQ、NMN系列产品、维生素A、维生素D、吡喹酮、丙氨酰谷氨酰胺、奥拉西坦等医药原料。公司及全资子公司获得9项专利证书（发明专利7项，实用新型专利2项）。","serverTime":1722108078985,"listedPrice":35,"stockholders":"52666人(较上一季度增加15.41%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金达威(002626)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金达威(002626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金达威,002626,金达威股票,金达威股票老虎,金达威股票老虎国际,金达威行情,金达威股票行情,金达威股价,金达威股市,金达威股票价格,金达威股票交易,金达威股票购买,金达威股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金达威(002626)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金达威(002626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}